Business Context and Reporting Period
This Form 8-K Current Report was filed by Illumina, Inc. on January 27, 2016. The filing reports a corporate governance event regarding the composition of the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel appointment and does not contain financial statements or performance data.
Material Changes
The primary material change reported is the expansion of the Board of Directors:
- The Board size increased from 10 to 11 members effective January 27, 2016.
- Frances Arnold, Ph.D. was elected to serve on the Board.
- Dr. Arnold is assigned to the class of directors standing for election at the 2016 annual meeting of stockholders.
- She will serve a three-year term commencing with the 2016 annual meeting.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. Regarding risks and contingencies:
- There is no arrangement or understanding between Dr. Arnold and any other person pursuant to which she was selected.
- Dr. Arnold is not a party to any transaction with the Company reportable under Item 404(a) of Regulation S-K.
- Dr. Arnold will participate in the non-employee director compensation programs described in the Company's proxy statement filed on April 8, 2015.
Key Facts for Investor Verification
- Verify the effective date of Dr. Frances Arnold's appointment (January 27, 2016).
- Confirm the new total size of the Board of Directors (11 members).
- Review the press release filed as Exhibit 99.1 for additional biographical details on Dr. Arnold.
- Check the Company's proxy statement filed on April 8, 2015, for details on the non-employee director compensation program applicable to Dr. Arnold.